Glioblastomas are highly malignant primary brain tumors with one of the worst survival rates among all human cancers. With a more profound understanding of the cellular and molecular mechanisms of tumor initiation and acquired resistance to conventional radio- and chemotherapy, novel therapeutic targets might be discovered to optimize therapeutic approaches. In this regard, the identification of a small cellular subpopulation, called glioblastoma stem cell or stem-like cells or glioma-initiating cells or brain tumor propagating cells, has gained attention. In this article, we briefly summarize the current state of knowledge about this tumor cell population and discuss future directions for basic and clinical researc
Gliomas are the most incident brain tumor in adults. This malignancy has very low survival rates, ev...
With the advent of the cancer stem cell hypothesis, the field of cancer research has experienced a r...
Malignant primary brain tumors are characterized by a short median survival and an almost 100% tumor...
Glioblastomas are highly malignant primary brain tumors with one of the worst survival rates among a...
This review presents compelling evidence that human glioblastoma is a heterogenous tumor composed fr...
Malignant gliomas, particularly glioblastoma multiforme (GBM), account for the majority of brain tum...
Glioblastoma is the most common and highly malignant primary brain tumor, and patients affected with...
Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.Cancer stem cells (CSC...
The discovery of glioblastoma stem cells (GSCs) in the 2000s revolutionized the cancer research fiel...
Glioblastoma (GBM) is known to be the most common and lethal primary malignant brain tumor. Therapie...
Glioblastomas (GBMs) are highly lethal primary brain tumors. Despite current therapeutic advances in...
Despite therapeutic advances, glioblastoma multiforme (GBM) remains a lethal disease. The infiltrati...
Glioblastoma multiforme (GBM) is among the most incurable cancers. GBMs survival rate has not marked...
Glioblastoma multiforme (GBM) is the most common adult primary brain tumor and is comprised of a het...
Copyright © 2014 Davide Schiffer et al.This is an open access article distributed under the Creative...
Gliomas are the most incident brain tumor in adults. This malignancy has very low survival rates, ev...
With the advent of the cancer stem cell hypothesis, the field of cancer research has experienced a r...
Malignant primary brain tumors are characterized by a short median survival and an almost 100% tumor...
Glioblastomas are highly malignant primary brain tumors with one of the worst survival rates among a...
This review presents compelling evidence that human glioblastoma is a heterogenous tumor composed fr...
Malignant gliomas, particularly glioblastoma multiforme (GBM), account for the majority of brain tum...
Glioblastoma is the most common and highly malignant primary brain tumor, and patients affected with...
Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.Cancer stem cells (CSC...
The discovery of glioblastoma stem cells (GSCs) in the 2000s revolutionized the cancer research fiel...
Glioblastoma (GBM) is known to be the most common and lethal primary malignant brain tumor. Therapie...
Glioblastomas (GBMs) are highly lethal primary brain tumors. Despite current therapeutic advances in...
Despite therapeutic advances, glioblastoma multiforme (GBM) remains a lethal disease. The infiltrati...
Glioblastoma multiforme (GBM) is among the most incurable cancers. GBMs survival rate has not marked...
Glioblastoma multiforme (GBM) is the most common adult primary brain tumor and is comprised of a het...
Copyright © 2014 Davide Schiffer et al.This is an open access article distributed under the Creative...
Gliomas are the most incident brain tumor in adults. This malignancy has very low survival rates, ev...
With the advent of the cancer stem cell hypothesis, the field of cancer research has experienced a r...
Malignant primary brain tumors are characterized by a short median survival and an almost 100% tumor...